CD274 and posterior cortical atrophy: Among those, there are acapatamab (AMG160), a PSM—bispecific T-cell engager (NCT04631601, NCT03792841), M7824, a bifunctional fusion protein targeting TGF-β and PD-L1 (NCT04633252), and W_pro1 (BNT112), an mRNA targeting five antigens expressed in PCa cells (PRO-MERIT trial, NCT04382898).